Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
110995101000001118 | Propranolol 160mg modified-release / Bendroflumethiazide 5mg capsules (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
110995201000001113 | Propranolol 160mg modified-release / Bendroflumethiazide 5mg capsules | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Propranolol 160mg modified-release / Bendroflumethiazide 5mg capsules 28 capsule | Has VMP | True | Propranolol 160mg modified-release / Bendroflumethiazide 5mg capsules | Inferred relationship | Existential restriction modifier | |
Inderex 160mg/5mg modified-release capsules (AstraZeneca) | Is a | True | Propranolol 160mg modified-release / Bendroflumethiazide 5mg capsules | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets